公开(公告)号：WO2004087181A8

公开(公告)日：2004-12-29

申请号：PCT/EP2004003401

申请日：2004-03-31

Applicant: BIOPLANTA ARZNEIMITTEL GMBH ,  KOCH EGON ,  STUMPF KARL-HEINZ

Inventor： KOCH EGON ,  STUMPF KARL-HEINZ

IPC: A61K36/00 ,  A61K36/16 ,  A61K36/185 ,  A61K36/38 ,  A61K36/45 ,  A61K36/48 ,  A61K36/535 ,  A61K36/55 ,  A61K36/72 ,  A61K36/73 ,  A61K36/734 ,  A61K36/77 ,  A61K36/80 ,  A61K36/87 ,  A61P37/00 ,  A61K35/78

CPC classification number: A61K36/185 ,  A61K36/16 ,  A61K36/38 ,  A61K36/45 ,  A61K36/48 ,  A61K36/535 ,  A61K36/55 ,  A61K36/72 ,  A61K36/73 ,  A61K36/734 ,  A61K36/77 ,  A61K36/80 ,  A61K36/87 ,  A61K2300/00

Abstract: The invention relates to active ingredient combinations of oils containing omega3-fatty acids and plant extracts containing polyphenols and the use thereof for the treatment of inflammatory and/or immunological and metabolic diseases and other ailments.

Abstract translation: 本发明涉及含有ω-3脂肪酸的油与含多酚植物提取物的活性化合物组合以及它们用于治疗炎症和/或免疫学以及代谢疾病和其它病症的用途。

公开(公告)号：WO02069963A3

公开(公告)日：2002-11-14

申请号：PCT/US0206091

申请日：2002-02-27

Applicant: MURAD HOWARD

Inventor： MURAD HOWARD

IPC: A61K8/365 ,  A61K8/44 ,  A61K8/60 ,  A61K8/97 ,  A61K31/192 ,  A61K31/198 ,  A61K31/366 ,  A61K31/7024 ,  A61K36/076 ,  A61K36/16 ,  A61K36/185 ,  A61K36/23 ,  A61K36/233 ,  A61K36/236 ,  A61K36/28 ,  A61K36/29 ,  A61K36/30 ,  A61K36/328 ,  A61K36/48 ,  A61K36/484 ,  A61K36/515 ,  A61K36/53 ,  A61K36/55 ,  A61K36/70 ,  A61K36/71 ,  A61K36/734 ,  A61K36/76 ,  A61K36/886 ,  A61K36/8945 ,  A61K36/9068 ,  A61P17/00 ,  A61Q19/00 ,  A61K7/48 ,  A61K35/78

CPC classification number: A61K36/484 ,  A61K8/365 ,  A61K8/447 ,  A61K8/602 ,  A61K8/97 ,  A61K31/192 ,  A61K31/198 ,  A61K31/366 ,  A61K31/7024 ,  A61K36/076 ,  A61K36/16 ,  A61K36/185 ,  A61K36/23 ,  A61K36/233 ,  A61K36/236 ,  A61K36/28 ,  A61K36/29 ,  A61K36/30 ,  A61K36/328 ,  A61K36/48 ,  A61K36/515 ,  A61K36/53 ,  A61K36/55 ,  A61K36/70 ,  A61K36/71 ,  A61K36/734 ,  A61K36/76 ,  A61K36/886 ,  A61K36/8945 ,  A61K36/9068 ,  A61Q19/00 ,  A61K2300/00

Abstract: The invention relates to dermatological agents and methods for treating dermatological disorders. The dermatological agents include a therapeutically effective amount of at least one acid selected from ellagic acid, ferrulic acid, caffeic acid, or tannic acid in an amount sufficient to strengthen cell membranes in the skin. The at least one acid is preferably combined with at least one of a moisturizing agent, an anti-inflammatory component, an immunity boosting component or an additional anti-oxidant, and a pharmaceutically acceptable carrier.

Abstract translation: 本发明涉及皮肤病学药剂和治疗皮肤病的方法。 皮肤病药包括治疗有效量的至少一种选自鞣花酸，马来酸，咖啡酸或丹宁酸的酸，其量足以增强皮肤中的细胞膜。 所述至少一种酸优选与保湿剂，抗炎成分，免疫增强组分或其它抗氧化剂和药学上可接受的载体中的至少一种组合。

公开(公告)号：WO0189319A3

公开(公告)日：2002-08-01

申请号：PCT/CA0100736

申请日：2001-05-24

Applicant: HUDSON SUSAN P ,  HUDSON CRAIG J

Inventor： HUDSON SUSAN P ,  HUDSON CRAIG J

IPC: A23L2/52 ,  A21D2/36 ,  A21D13/08 ,  A23J1/00 ,  A23J1/14 ,  A23L1/20 ,  A23L1/30 ,  A23L1/305 ,  A23L1/36 ,  A61K9/06 ,  A61K9/08 ,  A61K9/10 ,  A61K9/14 ,  A61K9/20 ,  A61K9/48 ,  A61K31/405 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/7004 ,  A61K31/7016 ,  A61K36/00 ,  A61K36/31 ,  A61K36/55 ,  A61K38/00 ,  A61P3/00 ,  A61P25/20 ,  A61P25/22 ,  A61P25/24 ,  A61P29/00 ,  A61P43/00 ,  A21D2/24 ,  A21D2/26

CPC classification number: A23J1/006 ,  A23J1/14 ,  A23L11/05 ,  A23L25/30 ,  A23L33/185 ,  A23V2002/00 ,  Y10S514/909 ,  Y10S514/91 ,  Y10S514/923 ,  A23V2250/065 ,  A23V2250/7046 ,  A23V2250/7052

Abstract: Compositions are described comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, preferably squash seeds, and, optionally, a carbohydrate source provided in an amount capable of facilitating transport of in vivo generated tryptophan across the blood brain barrier. Also described are dietary supplements, foods and beverages comprising the composition of the invention to induce sleep or provide tryptophan supplementation to individuals in need thereof.

Abstract translation: 描述了组合物，其包含来自含有蛋白质结合的色氨酸，优选南瓜种子的植物来源的至少部分脱脂的膳食，以及任选的提供的量的能够促进体内产生的色氨酸的量的碳水化合物源 横跨血脑屏障。 还描述了包含本发明组合物的膳食补充剂，食品和饮料以诱导睡眠或向有需要的个体补充色氨酸。

公开(公告)号：WO0230404A2

公开(公告)日：2002-04-18

申请号：PCT/CA0101423

申请日：2001-10-12

Applicant: BIORIGINAL FOOD & SCIENCE CORP ,  KAPOOR RAKESH ,  BERRUTI ALESSANDRA

Inventor： KAPOOR RAKESH ,  BERRUTI ALESSANDRA

IPC: A61K31/00 ,  A61K31/20 ,  A61K31/355 ,  A61K36/185 ,  A61K36/30 ,  A61K36/35 ,  A61K36/45 ,  A61K36/535 ,  A61K36/55 ,  A61K36/752 ,  A61K36/85 ,  A61P15/00

CPC classification number: A61K36/30 ,  A61K36/185 ,  A61K36/35 ,  A61K36/45 ,  A61K36/535 ,  A61K36/55 ,  A61K36/752 ,  A61K36/85 ,  A61K2300/00

Abstract: Disclosed is a composition comprising ingredients a-f: a) n-6 fatty acid; b) n-3 fatty acid; c) vitamin E; d) extract of Viburnum opulus bark; e) extract of Vitex agnus castus berry; and f) bioflavonoid(s). Also disclosed is a method of treating premenstrual symptoms in a subject in need of such treatment and a method of treating irritable bowel syndrome or interstitial cystitis in a subject in need of such treatment. The method comprises the step of administering to the subject a therapeutically effective amount of the ingredients a-f, described above. Preferably, the subject is administered a composition comprising ingredients a-f.

Abstract translation: 公开了一种组合物，其包含成分a-f：a）n-6脂肪酸; b）n-3脂肪酸; c）维生素E; d）荚膜桉树皮提取物; e）Vitex agnus castus 浆果的提取物; 和f）生物类黄酮（s）。 还公开了一种在需要这种治疗的受试者中治疗经前症状的方法和在需要这种治疗的受试者中治疗肠易激综合征或间质性膀胱炎的方法。 该方法包括向受试者施用治疗有效量的上述成分a-f的步骤。 优选地，给予受试者包含成分a-f的组合物。

公开(公告)号：WO00049896A1

公开(公告)日：2000-08-31

申请号：PCT/US2000/004677

申请日：2000-02-24

IPC: A23K1/16 ,  A23K1/165 ,  A23K1/18 ,  A23L1/30 ,  A61K31/35 ,  A61K31/365 ,  A61K31/37 ,  A61K36/55 ,  A61K45/06 ,  A61P3/04 ,  A61K31/352 ,  A61K31/7048

CPC classification number: A23K50/40 ,  A23K20/10 ,  A23K20/111 ,  A23K20/158 ,  A23K20/163 ,  A23K20/168 ,  A23K20/184 ,  A23K20/20 ,  A23K50/00 ,  A23K50/20 ,  A23L33/11 ,  A61K31/35 ,  A61K31/365 ,  A61K31/37 ,  A61K45/06 ,  A61K2300/00

Abstract: Dietary compositions and methods employ a mammal food base and a component comprising estrogen, androgen or a mixture thereof in an amount sufficient to reduce weight gain normally incurred in the mammal type subsequent to neutering, castration, spaying, ovariectomy or ovariohysterectomy, or post menopause. Preferably, the component comprises phytoestrogen, phytoandrogen or a mixture thereof. The compositions are adapted for administration to the mammal on a regular, preferably daily, basis.

Abstract translation: 饮食组合物和方法使用哺乳动物食物基质和包含雌激素，雄激素或其混合物的组分，其含量足以减少在阉割，去势，喷洒，卵巢切除术或卵巢切除术或更年期后通常在哺乳动物类型中发生的体重增加。 优选地，组分包括植物雌激素，植物雄激素或其混合物。 该组合物适于以规则，优选每日为基础向哺乳动物施用。

公开(公告)号：WO99066913A2

公开(公告)日：1999-12-29

申请号：PCT/IT1999/000174

申请日：1999-06-17

IPC: A23L1/30 ,  A61K31/00 ,  A61K31/205 ,  A61K31/35 ,  A61K31/352 ,  A61K36/00 ,  A61K36/18 ,  A61K36/55 ,  A61P15/12 ,  A61P19/10 ,  A61P43/00

CPC classification number: A61K31/35 ,  A61K2300/00

Abstract: A composition that may take the form of a dietary supplement or of an actual medicine is disclosed which comprises as characterizing active ingredients propionyl L-carnitine and the isoflavone genistein for the prevention and/or therapeutic treatment of osteoporosis and menopause syndrome.

Abstract translation: 可以采取膳食补充剂或实际药物形式的组合物，其包括作为表征活性成分丙酰基左旋肉碱和异黄酮染料木素用于预防和/或治疗性治疗骨质疏松症和更年期综合征的组合物。

公开(公告)号：WO2019213464A1

公开(公告)日：2019-11-07

申请号：PCT/US2019/030518

申请日：2019-05-03

Applicant: THE PROCTER & GAMBLE COMPANY

Inventor： HODGDON, Travis, Kyle ,  LAUGHLIN, Leo, Timoth, III ,  WANG, Samantha, Chen-Yee ,  BINDER, Robert, Lloyd

IPC: A61K36/9062 ,  A61K36/185 ,  A61K36/35 ,  A61K36/55 ,  A61K36/68 ,  A61K36/28 ,  A61P15/00

Abstract: A method of treating vaginal atrophy is provided. The method comprises administering a vaginal care composition to vaginal tissue of a user experiencing a symptom of vaginal atrophy. The vaginal care composition may include an effective amount of a vaginal care agent selected to specifically treat symptoms of vaginal atrophy exhibited by the introitus and/or labia, based on the transcriptomic data of skin cells obtained therefrom. In some instances, the vaginal care composition may be applied to introitus and/or labia with a suitable implement configured for such use.

公开(公告)号：WO2018226191A3

公开(公告)日：2018-12-13

申请号：PCT/TR2018/050102

申请日：2018-03-16

Applicant: HELVACIZADE GIDA İLAÇ KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİ

Inventor： BÜYÜKHELVACIGİL, Mevlüt

IPC: A61K36/55 ,  A61P1/00 ,  A61K9/48 ,  A61K47/22

Abstract: In pharmaceutical industry; the invention relates to use of an herbal formulation containing linseed oil being rich in alpha-linolenic acid (ALA) that is a herbal Omega 3 fatty acid in the treatment of gastrointestinal (related to gastrointestinal system) disorders. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerin, purified water and gelatin maintaining the integrity and formation of the content.

公开(公告)号：WO2018226190A9

公开(公告)日：2018-12-13

申请号：PCT/TR2018/050101

申请日：2018-03-16

Applicant: HELVACIZADE GIDA İLAÇ KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİ

Inventor： BÜYÜKHELVACIGİL, Mevlüt

IPC: A61P1/10 ,  A61K36/55 ,  A61K9/48

Abstract: In pharmaceutical industry; the invention relates to use of an herbal formulation containing linseed oil being rich in alpha-linolenic acid (ALA) that is a herbal Omega 3 fatty acid in the treatment of chronic constipation. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerin, purified water and gelatin maintaining the integrity and formation of the content.

公开(公告)号：WO2018222167A9

公开(公告)日：2018-12-06

申请号：PCT/TR2018/050093

申请日：2018-03-09

Applicant: HELVACIZADE GIDA İLAÇ KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİ

Inventor： BÜYÜKHELVACIGİL, Mevlüt

IPC: A61K36/55 ,  A61P9/00

Abstract: In pharmaceutical industry; the invention relates to use of an herbal formulation containing linseed oil being rich in alpfa-linolenic acid (ALA) that is an herbal Omega 3 fatty acid in the treatment of cardiovascular system diseases. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerine, purified water and gelatine maintaining the integrity and formation of the content.